BOSTON, Jan. 28, 2026 /PRNewswire/ -- Stellaromics, a pioneer in high-resolution 3D spatial biology, today announced the installation of its Pyxa™ 3D spatial multi-omics system at Emory University ...
Stellaromics today launched Pyxa™, the first commercially available platform to deliver multiplexed 3D spatial transcriptomics in intact tissue up to 100 micrometers thick. The launch marks a ...
Spatial transcriptomics is transforming how scientists see biology—literally—by mapping gene activity in its original location inside tissues. From decoding tumor architecture to charting entire ...
BOSTON, Oct. 14, 2025 /PRNewswire/ -- Stellaromics, a pioneer in 3D spatial biology, today announces the installation of the first Pyxa™ instrument at the University of Glasgow in the laboratory of Dr ...
Renowned vision researcher Dr. Rui Chen to apply 3D spatial multi-omics for mapping sensory systems and advancing Human Cell Atlas discoveries BOSTON, Dec. 3, 2025 /PRNewswire/ -- Stellaromics, a ...
Spatial transcriptomics is revolutionizing the study of tissue architecture, cellular states, and tumor-immune interactions in clinical specimens. This presentation introduces the principles and ...
The rapid development of spatial transcriptomics (ST) technologies has greatly advanced the understanding of gene expression, tissue architecture, cellular composition, and disease mechanisms within ...
Hosted on MSN
What Is Spatial Transcriptomics?
Spatial transcriptomics is a technique that provides information about gene expression patterns within intact tissues. This technology employs various methodologies, including in situ sequencing (ISS) ...
Knowing the location of a gene within intact tissue or a single cell allows scientists to unlock unknown cellular functions. This information is often lost in most genetic sequencing techniques, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results